Tweet Tweet!
We are delighted to introduce the inaugural team of Pharmacological Reviews Social Media Ambassadors!
This dynamic quartet is generously volunteering their time to help promote articles published in Pharmacological Reviews via social media forums, Twitter in particular. They have already been hard at work behind the scenes developing improved strategies for disseminating Pharmacological Reviews publications. Search @PharmRevJournal on Twitter to see their first Tweets on the July 2022 issue!
Check out “Ambassador Picks” on the journal homepage for featured review articles. By having an official team of social media experts, our goal is to increase journal visibility and readership.
Follow us for more tweets from our Ambassadors on upcoming Pharmacological Reviews issues.
Lynette C. Daws, Ph.D.Editor
Meet the dynamic quartet of social media ambassadors:
Footnotes
- Received July 20, 2022.
- Accepted July 20, 2022.
- Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics
Lindsey Galbo is a doctoral candidate in the Integrative Physiology and Pharmacology program at Wake Forest University Graduate School of Arts and Sciences, Winston-Salem, NC. She is interested in the behavioral pharmacology of drugs and currently works with a nonhuman primate model of alcohol use disorder.
Rheure Lopes, Ph.D., is a native Brazilian currently living in Scotland and working as a postdoctoral fellow at the Institute for Cardiovascular and Medical Sciences at the University of Glasgow. Rheure seeks to understand the mechanisms involved in hypertension-associated vascular damage.
Joshua Lott, Ph.D., is a recent graduate in pharmacology from the University of Michigan. Josh says that his time as a graduate student helped him understand the significance of scientific outreach and communication. Josh also serves as the social media coordinator for Pharmacology Research & Perspectives. He currently works in medical affairs as a medical science liaison.
Karla Neves, Ph.D., is a postdoctoral fellow at the Institute for Cardiovascular and Medical Sciences at the University of Glasgow, UK, working on the cardiovascular effects of anticancer drugs.
